2023-08-09 07:20:21 ET
- LENSAR press release ( NASDAQ: LNSR ): Q2 GAAP EPS of -$0.81 misses by $0.46 .
- Revenue of $12.01M (+49.4% Y/Y) beats by $2.01M .
- Increased ALLY ® Adaptive Cataract Treatment System installed base to 28 systems with a backlog of 6 additional systems for installation as of June 30, 2023
- U.S. procedure volumes increased 13% over second quarter 2022; 1H 2023 procedure volumes increased 15% year-over-year at sites that have upgraded from LENSAR Laser System or added an ALLY
- $25.5 million cash available to support ongoing ALLY commercial launch activities and market expansion initiatives.
For further details see:
LENSAR GAAP EPS of -$0.81 misses by $0.46, revenue of $12.01M beats by $2.01M